Approval · Notice of Compliance 4701 · 1996
RESTORIL: Notice of Compliance 4701
Issued October 25, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4701
- Date
- October 25, 1996
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Hypnotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESTORIL | 02229854 | — |
Medicinal ingredients
- TEMAZEPAM 7.5 MG per CAP